PRPH
ProPhase Labs, Inc.
OTC Pharmaceutical Preparations Non-accelerated filer
Smaller reporting company

Key Financials

Net Income
$-14743000
↑ 72.4%
Revenue
$4.3M
↓ 35.8%
Operating Income
$-18047000
↑ 53.3%
Gross Profit
$1.4M
↑ 1022.7%
EPS (Diluted)
$-1.74
↑ 33.3%
Total Assets
$59.9M
↓ 5.3%
Total Liabilities
$56.4M
↑ 0.9%
Cash & Equivalents
$90000.00
↓ 86.7%

Recent SEC Filings

Form Type Filed Date Link
NT 10-Q 8/14/2026 View on SEC
8-K 8/6/2026 View on SEC
10-Q/A 7/9/2026 View on SEC
10-Q/A 7/7/2026 View on SEC
10-Q 6/30/2026 View on SEC
10-K 6/1/2026 View on SEC
NT 10-Q 5/15/2026 View on SEC
NT 10-K 3/27/2026 View on SEC
8-K 2/13/2026 View on SEC
8-K 2/13/2026 View on SEC

Company Information

Field Value
Ticker PRPH
Company Name ProPhase Labs, Inc.
CIK 868278
Sector Pharmaceutical Preparations
Industry Non-accelerated filer
Smaller reporting company
Exchange OTC
SIC Code 2834
SIC Description Pharmaceutical Preparations
Entity Type operating
Fiscal Year End 1231
State of Incorporation DE
Phone (215) 345-0919